Liponorm (Simvastatin)

Simvastatin blocks the enzyme HMG‑CoA reductase, the key step in liver cholesterol production. This inhibition lowers intracellular cholesterol, leading the liver to increase LDL‑receptor numbers and clear more LDL cholesterol from the bloodstream.

The appropriate dose of Liponorm is determined by the prescribing clinician based on the patient’s cholesterol levels, cardiovascular risk profile, and any concomitant medications. Dosage adjustments are made according to clinical response and safety monitoring.

Simvastatin is classified as pregnancy category X, meaning it is contraindicated in pregnancy because of potential fetal harm. It is also not recommended while breastfeeding, as it may pass into breast milk and affect the infant.

To order Liponorm, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Liponorm (simvastatin) is a moderate‑potency statin with a well‑established efficacy‑safety profile. Compared with higher‑potency agents such as rosuvastatin, simvastatin may require higher doses to achieve similar LDL‑cholesterol reductions, but it is often less expensive and widely available.

Store Liponorm at room temperature, below 25 °C, in the original container to protect it from moisture and light. Keep the product out of reach of children and avoid exposing it to extreme temperatures or humidity.

Liponorm is taken orally, usually once daily in the evening with or without food, as directed by the prescriber. Consistency in timing helps maintain stable drug levels and maximizes cholesterol‑lowering effect.

The most serious risks include rhabdomyolysis, a severe muscle breakdown that can lead to kidney failure, and significant liver injury. Patients should report unexplained muscle pain, weakness, or dark urine promptly, and liver function should be monitored regularly.

Liponorm should not be used by individuals who are pregnant, nursing, have active liver disease, or have a known hypersensitivity to simvastatin or any of its excipients. Caution is also advised in patients taking strong CYP3A4 inhibitors.